Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Saved in:
| Title: | Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. |
|---|---|
| Authors: | Vaccaro K; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Allen J; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Whitfield TW; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Maoz A; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.; Dana-Farber Cancer Institute; Boston, MA 02115, USA., Reeves S; Massachusetts General Hospital Cancer Center; Boston, MA 02129, USA., Velarde J; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Yang D; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Phan N; Massachusetts General Hospital Cancer Center; Boston, MA 02129, USA., Bell GW; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA., Hata AN; Massachusetts General Hospital Cancer Center; Boston, MA 02129, USA., Weiskopf K; Whitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.; Dana-Farber Cancer Institute; Boston, MA 02115, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2023 Mar 06. Date of Electronic Publication: 2023 Mar 06. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
